MedTrace Logo

Pharmacokinetic Interaction Between HGP0904, HGP0608 and HGP1405

NCT02387554 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2015-06-12

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to investigate the pharmacokinetic interaction and safety between HGP0904, HGP0608 and HGP1405 when administered alone and in combination in healthy male volunteers

Conditions

  • Hypertension(HTN)

Interventions

DRUG

HGP0904

DRUG

HGP0608

DRUG

HGP1405

Sponsors & Collaborators

  • Seoul National University Bundang Hospital

    collaborator OTHER

  • Hanmi Pharmaceutical Company Limited

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2014-10-31
Completion
2014-10-31

Countries

  • South Korea

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02387554 on ClinicalTrials.gov